Filing Flows

Filing Flows › Comparisons › WGS vs DCGO

GeneDx Holdings vs DocGo: WGS and DCGO compared

GeneDx Holdings is the larger company: $114M of revenue in its latest quarter (Q2 2026) against $73.4M for DocGo (Q2 2026). GeneDx Holdings is growing faster (+11% against -9% a year earlier). GeneDx Holdings is more profitable, with an operating margin of -15.3% against -24.4%.

GeneDx Holdings vs DocGo, latest quarterGeneDx Holdings vs DocGo, latest quarterGeneDx Holdings (WGS)DocGo (DCGO)Revenue$114M$73.4MRevenue growth, Y/Y+11%-9%Operating margin-15.3%-24.4%Net margin-15.5%-24.5%

Where the money goes: WGS and DCGO

GeneDx Holdings (WGS) · Q2 2026

GeneDx Holdings, Q2 2026: revenue $114M (+11% year over year), operating margin -15.3%, net loss $17.7M, operating cash flow −$29.0M. The chart follows the revenue to costs, profit and cash.

DocGo (DCGO) · Q2 2026

DocGo, Q2 2026: revenue $73.4M (-9% year over year), operating margin -24.4%, net loss $18.0M, operating cash flow −$9.2M. The chart follows the revenue to costs, profit and cash.

GeneDx Holdings revenue by segment, Q2 2026GeneDx Holdings revenue by segment, Q2 2026Diagnostic Test$112MOther revenue$2.6M
DocGo revenue by segment, Q2 2026DocGo revenue by segment, Q2 2026Transportation Services$52.0MMobile Health Services$21.4M
GeneDx Holdings (WGS)DocGo (DCGO)
Latest quarterQ2 2026Q2 2026
Revenue$114M$73.4M
Revenue growth, Y/Y+11%-9%
Operating margin-15.3%-24.4%
Net earnings−$17.7M−$18.0M
Net margin-15.5%-24.5%
Operating cash flow−$29.0M−$9.2M
Market value$2.0B—
Analysts’ mean target$93.50—

Where the revenue comes from

GeneDx Holdings

DocGo

Questions

Which is bigger, GeneDx Holdings or DocGo?

GeneDx Holdings is the larger company: $114M of revenue in its latest quarter (Q2 2026) against $73.4M for DocGo (Q2 2026).

Is GeneDx Holdings or DocGo growing faster?

GeneDx Holdings is growing faster (+11% against -9% a year earlier).

Which is more profitable, GeneDx Holdings or DocGo?

GeneDx Holdings is more profitable, with an operating margin of -15.3% against -24.4%.

More: GeneDx Holdings earnings · how GeneDx Holdings makes money · DocGo earnings · how DocGo makes money

From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Aug 3, 2026; 10-Q filed Aug 17, 2026). Fiscal quarters can end on different dates. Not investment advice.